Targeting Microglial Metabolic Rewiring Synergizes with Immune Checkpoint Blockade Therapy for Glioblastoma.
Cancer Discov. 2023 Jan 17:CD-22-0455. doi: 10.1158/2159-8290.CD-22-0455. Online ahead of print.
Cancer Discov. 2023.
PMID: 36649564